Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Using a Fine-Tuned Commercial Artificial Intelligence Model to Assess Nutrients from Photographs of Japanese Meals.

Journal of diabetes science and technology·2026

Same author

Digital Intervention Increasing Sleep Duration Among People With Type 2 Diabetes: Pilot Randomized Controlled Trial.

Journal of diabetes science and technology·2026

Same author

Research Code Sharing in Support of Gold Standard Science.

Journal of diabetes science and technology·2026

Same author

Efficacy of FiberMore, an AI-Based mHealth Intervention to Increase Dietary Fiber Intake Among Type 2 Diabetes Patients: Protocol for a Pilot Randomized Controlled Trial.

JMIR research protocols·2025

Same author

Dietary Fiber Estimate of DialBetesPlus App Users: Secondary Analysis of Data From a Randomized Controlled Trial.

JMIR formative research·2025

Same author

Elucidating Celecoxib's Preventive Effect in Capecitabine-Induced Hand-Foot Syndrome Using Medical Natural Language Processing.

JCO clinical cancer informatics·2025

Search research articles

Related Experiment Video

Updated: Jun 20, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Enhancing Type 2 Diabetes Treatment Decisions With Interpretable Machine Learning Models for Predicting Hemoglobin

Hisashi Kurasawa^1,2, Kayo Waki², Tomohisa Seki²

¹Nippon Telegraph and Telephone Corporation, Tokyo, Japan.

|July 18, 2024

Summary

This summary is machine-generated.

This study developed a machine learning model to predict poor glycemic control in type 2 diabetes (T2D) patients. The model accurately identifies individuals needing intensified treatment, improving future health outcomes.

Keywords:

AI artificial intelligence attention weight blood glucose control machine learning transformer type 2 diabetes

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

Related Experiment Videos

Last Updated: Jun 20, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

Area of Science:

Biomedical Informatics
Machine Learning in Healthcare
Diabetes Management

Background:

Type 2 diabetes (T2D) poses a significant global health challenge.
Predicting future poor glycemic control is crucial for timely intervention but is complicated by factors like seasonal variations.
Physicians require tools to identify T2D patients at risk of poor glycemic control under usual care.

Purpose of the Study:

To develop and validate a predictive model for poor glycemic control in patients with T2D receiving standard care.
To accurately forecast the likelihood of future poor glycemic control (HbA1c ≥ 8%) based on historical HbA1c trends.

Main Methods:

A machine learning model utilizing a transformer architecture with an attention mechanism was developed.
The model processes irregularly spaced hemoglobin A1c (HbA1c) time series data to capture temporal relationships.
Model performance was evaluated on 7787 T2D patients' data and compared against the LightGBM model.

Main Results:

The proposed model achieved high prediction accuracy, with an area under the receiver operating characteristic curve of 0.925 and an area under the precision-recall curve of 0.864.
Prediction accuracy was comparable to or surpassed that of the LightGBM model.
The model demonstrated that recent HbA1c levels are most influential, with older levels having a slight edge in predicting poor glycemic control.

Conclusions:

The developed model accurately predicts poor glycemic control in T2D patients under usual care, including those undergoing treatment intensification.
Physicians can use this model to identify patients requiring extraordinary treatment measures.
The tool may also guide nonspecialists in referring patients to specialists when future poor glycemic control is indicated.